Acid resistant capsules

US9700517B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9700517-B2
Application numberUS-201414470442-A
CountryUS
Kind codeB2
Filing dateAug 27, 2014
Priority dateSep 24, 2009
Publication dateJul 11, 2017
Grant dateJul 11, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to new acid resistant hard pharmaceutical capsules, a process for their manufacture and use of such capsules particularly but not exclusively for oral administration of pharmaceuticals, veterinary products, food and dietary supplements to humans or animals. The capsules of the invention are obtained by aqueous compositions comprising a water soluble film forming polymer and gellan gum in a mutual weight ratio of 4 to 15 weight parts of gellan gum for 100 weight parts of film forming polymer.

First claim

Opening claim text (preview).

The invention claimed is: 1. An acid resistant hard pharmaceutical capsule shell comprising gellan gum and at least one water-soluble film forming polymer, wherein: the weight ratio of gellan gum to said at least one water soluble film forming polymer is between 4/100 to 15/100 parts by weight of gellan gum per 100 parts by weight of the at least one water soluble film forming polymer, wherein the at least one water soluble film forming polymer is selected from the group consisting of hydroxypropyl methyl cellulose; gelatin, pullulan, hydroxypropyl starch, and a mixture thereof, the capsule shell does not comprise additional gelling aids comprising cations, wherein cations are not present in an amount higher than the amount naturally present in the gellan gum, the capsule shell has a moisture content ranging from about 2% to about 16% over the total weight of the shell, and the capsule shell exhibits resistance to leakage of at least 1 hour at pH 1.2 in a USP-30 simulated gastric fluid. 2. An acid resistant hard pharmaceutical capsule comprising a capsule shell comprising gellan gum and at least one water-soluble film forming polymer, wherein: the weight ratio of gellan gum to said at least one water soluble film forming polymer is between 4/100 to 15/100 parts by weight of gellan gum per 100 parts by weight of the at least one water soluble film forming polymer, wherein the at least one water soluble film forming polymer is selected from the group consisting of hydroxypropyl methyl cellulose; gelatin, pullulan, hydroxypropyl starch, and a mixture thereof, the capsule shell does not comprise additional gelling aids, the capsule shell has a moisture content ranging from about 2% to about 16% over the total weight of the shell, and the capsule shell exhibits resistance to leakage of at least 1 hour at pH 1.2 in a USP-30 simulated gastric fluid. 3. The hard capsule according to claim 2 , wherein the capsule shell is filled with at least one substance selected from the group consisting of acid-instable substances and substances associated with gastric side effects in humans and/or animals. 4. A dip-molding process for the manufacture of an acid resistant hard pharmaceutical capsule shell as defined in claim 1 , said process comprising: dipping pins into an aqueous composition comprising gellan gum and at least one water-soluble film forming polymer in a ratio is between 4/100 to 15/100 parts by weight of gellan gum per 100 parts by weight of the at least one water soluble film forming polymer, wherein the at least one water soluble film forming polymer is selected from the group consisting of hydroxypropyl methyl cellulose; gelatin, pullulan, hydroxypropyl starch, and a mixture thereof, wherein the aqueous composition does not comprise additional gelling aids comprising cations, and wherein cations are not present in the aqueous composition in an amount higher than the amount naturally present in the gellan gum; withdrawing the dipping pins from the aqueous composition; and drying the composition adhered on the dipping pins so as to obtain an acid resistant hard pharmaceutical capsule shell that exhibits resistance to leakage of at least 1 hour at pH 1.2 in a USP-30 simulated gastric fluid. 5. A method of administering to a patient at least one substance selected from the group consisting of acid-instable substances and substances associated with gastric side effects, comprising oral administration to said patient of the acid resistant hard pharmaceutical capsule according to claim 2 , comprising the at least one substance. 6. A method of imparting acid resistance properties to a hard capsule shell comprising a mixture of gellan gum, the method comprising: preparing a hard capsule shell from an aqueous composition comprising gellan gum and at least one water-soluble film forming polymer in a ratio is between 4/100 to 15/100 parts by weight of gellan gum per 100 parts by weight of the at least one water soluble film forming polymer, wherein the at least one water soluble film forming polymer is selected from the group consisting of hydroxypropyl methyl cellulose; gelatin, pullulan, hydroxypropyl starch, and a mixture thereof, wherein the aqueous composition does not comprise additional gelling aids comprising cations, and wherein cations are not present in the aqueous composition in an amount higher than the amount naturally present in the gellan gum, and wherein the hard capsule shell prepared from the aqueous composition exhibits resistance to leakage of at least 1 hour at pH 1.2 in a USP-30 simulated gastric fluid.

Assignees

Inventors

Classifications

  • Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

  • Capsules · CPC title

  • Use of proteins, e.g. casein, gelatine or derivatives thereof, as moulding material · CPC title

  • Use of polysaccharides or derivatives as moulding material · CPC title

  • Use of starch or derivatives as moulding material · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9700517B2 cover?
The present invention relates to new acid resistant hard pharmaceutical capsules, a process for their manufacture and use of such capsules particularly but not exclusively for oral administration of pharmaceuticals, veterinary products, food and dietary supplements to humans or animals. The capsules of the invention are obtained by aqueous compositions comprising a water soluble film forming po…
Who is the assignee on this patent?
Capsugel Belgium Nv
What technology area does this patent fall under?
Primary CPC classification A61K9/4816. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).